![]() |
市场调查报告书
商品编码
1732961
肝炎诊断检测市场-全球产业规模、份额、趋势、机会和预测(按检测类型、地区和竞争细分,2020-2030 年)Hepatitis Diagnostic Test Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test Type, By Region and Competition, 2020-2030F |
2024 年全球肝炎诊断测试市场价值为 45.8 亿美元,预计到 2030 年将达到 65.1 亿美元,预测期内复合年增长率为 6.04%。全球性内肝炎(尤其是B型肝炎和C肝)的盛行率不断上升,推动了对准确、及时的诊断解决方案的需求。根据世界卫生组织统计,2021 年全球有近 3.25 亿人患有慢性肝炎,凸显了对有效诊断干预措施的迫切需求。这个市场受到人们意识的提高、技术进步以及早期检测以预防肝硬化和癌症等併发症的重要性的推动。各种检测方法(包括血清学、分子检测和肝功能检测)的出现拓宽了诊断能力。此外,创新的即时检验(POCT)设备使诊断变得更加容易,特别是在偏远或服务不足的地区。这些进步,加上政府措施和全球健康运动的加强,持续支撑市场的成长轨迹。
市场概览 | |
---|---|
预测期 | 2026-2030 |
2024年市场规模 | 45.8亿美元 |
2030年市场规模 | 65.1亿美元 |
2025-2030 年复合年增长率 | 6.04% |
成长最快的领域 | 血液检查 |
最大的市场 | 北美洲 |
全球肝炎负担不断上升
高昂的诊断费用
即时检验 (POCT)
The Global Hepatitis Diagnostic Test Market was valued at USD 4.58 billion in 2024 and is projected to reach USD 6.51 billion by 2030, growing at a CAGR of 6.04% during the forecast period. The increasing global prevalence of hepatitis, particularly Hepatitis B and C, is driving demand for accurate and timely diagnostic solutions. According to the World Health Organization, nearly 325 million individuals globally were living with chronic hepatitis in 2021, highlighting the urgent need for effective diagnostic interventions. This market is fueled by heightened awareness, technological advancements, and the importance of early detection to prevent complications like liver cirrhosis and cancer. The availability of various testing methods-including serology, molecular assays, and liver function tests-has broadened diagnostic capabilities. Furthermore, innovative point-of-care testing (POCT) devices are making diagnostics more accessible, especially in remote or underserved regions. These advancements, combined with increased government initiatives and global health campaigns, continue to bolster the market's growth trajectory.
Market Overview | |
---|---|
Forecast Period | 2026-2030 |
Market Size 2024 | USD 4.58 Billion |
Market Size 2030 | USD 6.51 Billion |
CAGR 2025-2030 | 6.04% |
Fastest Growing Segment | Blood Tests |
Largest Market | North America |
Key Market Drivers
Rising Global Hepatitis Burden
The growing prevalence of hepatitis infections worldwide is a major force driving the Hepatitis Diagnostic Test Market. According to WHO, in 2023, approximately 60 million individuals in the South-East Asia region alone were living with chronic hepatitis B. Global transmission is often exacerbated by unsafe medical practices, lack of clean water and sanitation, and insufficient access to healthcare. Compounding this issue is the silent nature of hepatitis, which frequently progresses without symptoms until advanced liver damage has occurred. Early and accurate diagnosis is thus critical to preventing severe health outcomes such as cirrhosis and liver cancer. Governments and healthcare organizations are ramping up national screening programs and awareness campaigns, encouraging regular testing for high-risk populations including healthcare workers, people living with HIV, and intravenous drug users. These efforts are significantly expanding access to diagnostic services and promoting timely medical intervention.
Key Market Challenges
High Diagnostic Costs
A major challenge in the Hepatitis Diagnostic Test Market is the high cost associated with testing, particularly for molecular diagnostics such as PCR. These tests require specialized reagents, sophisticated equipment, and skilled laboratory personnel, which collectively drive up costs. This is especially burdensome in low-resource settings or among uninsured populations, where affordability becomes a barrier to widespread testing. Operational expenses tied to equipment maintenance, laboratory infrastructure, and quality assurance further increase the cost of diagnosis. Moreover, patients often require multiple tests to monitor disease progression and treatment efficacy, adding to the financial burden. In regions where insurance coverage is limited or inconsistent, out-of-pocket costs may deter individuals from undergoing necessary diagnostic evaluations.
Key Market Trends
Point-of-Care Testing (POCT)
Point-of-care testing is emerging as a transformative trend in hepatitis diagnostics. These compact, portable devices allow for rapid testing outside traditional laboratory environments, greatly enhancing diagnostic reach in rural and underserved areas. POCT minimizes the need for specialized equipment and skilled personnel, enabling quick, onsite diagnosis that facilitates timely treatment initiation. This immediacy not only improves patient outcomes but also helps curb the transmission of hepatitis within communities. The accessibility and speed of POCT make it a practical solution for widespread screening efforts, particularly in primary care settings and mobile health units. As healthcare providers seek more efficient and decentralized diagnostic methods, the adoption of POCT is expected to accelerate, driving market innovation and growth.
In this report, the Global Hepatitis Diagnostic Test Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Hepatitis Diagnostic Test Market.
Global Hepatitis Diagnostic Test market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: